Blackstone Inc Vbi Vaccines Inc Transaction History

Blackstone Inc

  • $21.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$0.48 - $1.38 $895,917 - $2.58 Million
-1,866,495 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$0.47 - $1.05 $387,537 - $865,774
-824,547 Reduced 30.64%
1,866,495 $879,000
Q4 2018

Feb 14, 2019
BUY
$1.22 - $2.41 $3.28 Million - $6.49 Million
2,691,042 New
2,691,042 $4.31 Million

Others Institutions Holding VBIV

# of Institutions
2
Shares Held
688K
Call Options Held
0
Put Options Held
0
View Full List

About VBI Vaccines Inc

VBIV Quotes by TradingView
  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Blackstone Inc Portfolio

Follow Blackstone Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackstone Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email